VIA
CATX icon

Virtus Investment Advisers’s Perspective Therapeutics CATX Stock Holding History

Virtus Investment Advisers’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-47,307
Closed -$101K – 448
2025
Q1 		$101K Buy
+47,307
New +$142K 0.03% 418

Other funds holding CATX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NWMG
Nicholson Wealth Management Group Charlestown, South Carolina $170M AUM 10.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Virtus Investment Advisers's CATX Position: Q2 2025 in Review

Virtus Investment Advisers sold out of Perspective Therapeutics (CATX) in Q2 2025, closing a stake of 47,307 shares — an estimated $101K sold.

Virtus Investment Advisers first reported a position in CATX in Q1 2025 and held it in 1 quarter. The position peaked at $101K in Q1 2025. 97 funds tracked by Wall St. Rank hold CATX as of Q2 2025.

  • Virtus Investment Advisers reported no remaining Perspective Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Virtus Investment Advisers sold 47,307 Perspective Therapeutics shares in Q2 2025, an estimated $101K.
  • Virtus Investment Advisers first reported a position in Perspective Therapeutics in Q1 2025 and held it in 1 quarter.
  • Virtus Investment Advisers's Perspective Therapeutics position peaked at $101K in Q1 2025.
  • 97 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2025.

Based on Virtus Investment Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.